Summary
Guardant Health, Inc. (GH) announced a significant addition to its Board of Directors with the appointment of Musa Tariq, effective March 6, 2023. Mr. Tariq brings a wealth of marketing and brand leadership experience from prominent companies such as GoFundMe, Airbnb, Ford, Apple, and Nike. His appointment, which increases the Board size to nine directors, is intended to leverage his expertise in driving brand awareness and adoption, a valuable asset for a company focused on expanding its reach in the liquid biopsy market. Mr. Tariq will serve as a Class I director until the 2025 Annual Meeting of Stockholders and will also join the nominating and corporate governance committee. He will receive standard compensation for non-employee directors, including stock options and restricted stock units valued at $362,500, vesting over time. This strategic appointment underscores the company's commitment to strengthening its leadership team with seasoned professionals to support its growth and market penetration strategies.
Key Highlights
- 1Musa Tariq appointed as a Class I director to the Guardant Health Board, effective March 6, 2023.
- 2The Board size has been increased to nine directors to accommodate the new appointment.
- 3Mr. Tariq possesses extensive marketing and brand leadership experience from companies including GoFundMe, Airbnb, Ford, Apple, and Nike.
- 4He will serve on the nominating and corporate governance committee of the Board.
- 5Mr. Tariq will receive standard non-employee director compensation, including a stock option and restricted stock unit award totaling $362,500.
- 6Awards will vest over a four-year period, subject to continued service.
- 7The company has entered into a standard indemnification agreement with Mr. Tariq.